Question & Answer Responses:
Does treating the ADRs from checkpoint inhibitors reduce their anti-cancer efficacy? (Asked by Michele Ramien)
No, it does not. Thank you
(Answered by Mario Lacouture)
Meeting Videos:
Introduction
Panel Discussion Pharmacogenomics And Considerations For Implementation
Day 1, SESSION 1 Racial Disparities
Day 1, SESSION 1 Funding Opportunities in Adverse Drug Reactions & SJS/TEN Pharmacogenomics Research
Day 1, SESSION 2 Clinical Approaches Update on Management
Day 1, SESSION 3 Updates in Global Regulatory Science, Pharmacovigilance and Data Mining
Day 1, SESSION 3 Applications in the Electronic Health Record to Improve Drug Safety
Day 1, SESSION 4 Genomic Approaches for Prediction, Prevention, Treatment - Technologies & Discovery
Day 1, SESSION 5 Special Populations, Challenges and Diagnosis
Day 1, SESSION 6 Update in Ocular Science
Day 1, SESSION 7 Patient and Family Stories